General AML

Christoph Röllig | EHA 2018 | 90 mg vs. 60 mg daunorubicin in 7+3 standard induction for ND AML

L:

23rd Congress of the European Hematology Association, 14-17 June 2018, Stockholm, Sweden

Christoph Röllig: Carl Gustav Carus University Hospital, Dresden, DE

Interview topic: 90 mg versus 60 mg daunorubicin in 7+3 standard induction for ND AML

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF